The role of antibody structure (conformation) in solution rheology is probed. It is demonstrated here that pH-dependent changes in the tertiary structure of 2 mAb solutions lead to viscoelasticity and not merely a shear viscosity (η) increase. Steady shear flow curves on mAb solutions are reported over broad pH (3.0 ≤ pH ≤ 8.7) and concentration (2 mg/mL ≤ c ≤ 120 mg/mL) ranges to comprehensively characterize their rheology. Results are interpreted using size exclusion chromatography, differential scanning calorimetry, analytical ultracentrifugation, near-UV circular dichroism, and dynamic light scattering. Changes in tertiary structure with concentration lead to elastic yield stress and increased solution viscosity in solution of “mAb1.” T...
Highly concentrated (> 200 mg/mL) monoclonal antibody (mAb) formulations with low viscosities are st...
Concentrated solutions of monoclonal antibodies have attracted considerable attention due to their i...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...
The role of antibody structure (conformation) in solution rheology is probed. It is demonstrated her...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
The rheological properties of macromolecular and colloidal suspensions are dependent on the thermody...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
High protein titers are gaining importance in biopharmaceutical industry. A major challenge in the d...
AbstractProtein solution rheology data in the biophysics literature have incompletely identified fac...
This electronic version was submitted by the student author. The certified thesis is available in th...
Recently, reversible cluster formation was identified as an underlying cause of anomalously large so...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Antibody solutions deviate from the dynamical and rheological response expected for globular protein...
Antibody therapies are typically based on high-concentration formulations that need to be administer...
Highly concentrated (> 200 mg/mL) monoclonal antibody (mAb) formulations with low viscosities are st...
Concentrated solutions of monoclonal antibodies have attracted considerable attention due to their i...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...
The role of antibody structure (conformation) in solution rheology is probed. It is demonstrated her...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
The rheological properties of macromolecular and colloidal suspensions are dependent on the thermody...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
High protein titers are gaining importance in biopharmaceutical industry. A major challenge in the d...
AbstractProtein solution rheology data in the biophysics literature have incompletely identified fac...
This electronic version was submitted by the student author. The certified thesis is available in th...
Recently, reversible cluster formation was identified as an underlying cause of anomalously large so...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Antibody solutions deviate from the dynamical and rheological response expected for globular protein...
Antibody therapies are typically based on high-concentration formulations that need to be administer...
Highly concentrated (> 200 mg/mL) monoclonal antibody (mAb) formulations with low viscosities are st...
Concentrated solutions of monoclonal antibodies have attracted considerable attention due to their i...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...